PIN19 THE COST-EFFECTIVENESS ANALYSIS OF COMBINATION OF PEGINTERFERON ALFA-2A AND RIBAVIRIN VERSUS COMBINATION OF PEGINTERFERON ALFA-2B AND RIBAVIRIN IN CHRONIC HEPATITIS C IN POLAND
May 1, 2004, 00:00 AM
10.1016/S1098-3015(10)62487-4
https://www.valueinhealthjournal.com/article/S1098-3015(10)62487-4/fulltext
Section Title :
Section Order :
425
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)62487-4&doi=10.1016/S1098-3015(10)62487-4